OpenBilldrug price receipt

NADAC week of 2026-10-14

ACYCLOVIR 800 MG TABLET

For 30 tablets

Pharmacies pay

$5.82 filed

30 × $0.19403 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$11.69 estimated

$5.82 + $0.87 (15%) + $5.00 fee per fill = $11.69

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ACYCLOVIR 800 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as acyclovir.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Camber Pharmaceuticals, Inc. and AvPAK.

FDA lists it under 3 Established Pharmacologic Classes: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor and Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor.

The NADAC file of 2026-10-14 prices it under 20 NDCs (National Drug Codes); the FDA directory lists 18 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.82 for 30 tablets (30 × $0.19403 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Aurobindo Pharma Limited2$0.19403 per EA filed
Bionpharma Inc.2$0.19403 per EA filed
Camber Pharmaceuticals, Inc.2$0.19403 per EA filed
Carlsbad Technology, Inc.2$0.19403 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2$0.19403 per EA filed
Westminster Pharmaceuticals, LLC2$0.19403 per EA filed
Zydus Pharmaceuticals (USA) Inc.2$0.19403 per EA filed
American Health Packaging1$0.19403 per EA filed
Apotex Corp.1$0.19403 per EA filed
AvPAK1$0.19403 per EA filed
Chartwell RX, LLC1$0.19403 per EA filed
Not listed as a package in the FDA directory2$0.19403 per EA filed
All 20 NDCs, with labeler and price
  • 23155-0228-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 23155-0228-05 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 31722-0778-01 · Camber Pharmaceuticals, Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 31722-0778-05 · Camber Pharmaceuticals, Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 50268-0062-11 · not listed as a package in the FDA directory · $0.19403 per EA · eff. 2026-09-23 filed
  • 50268-0062-15 · AvPAK · $0.19403 per EA · eff. 2026-09-23 filed
  • 59651-0966-01 · Aurobindo Pharma Limited · $0.19403 per EA · eff. 2026-09-23 filed
  • 59651-0966-05 · Aurobindo Pharma Limited · $0.19403 per EA · eff. 2026-09-23 filed
  • 60505-5307-01 · Apotex Corp. · $0.19403 per EA · eff. 2026-09-23 filed
  • 60687-0867-01 · American Health Packaging · $0.19403 per EA · eff. 2026-09-23 filed
  • 60687-0867-11 · not listed as a package in the FDA directory · $0.19403 per EA · eff. 2026-09-23 filed
  • 61442-0113-01 · Carlsbad Technology, Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 61442-0113-05 · Carlsbad Technology, Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 62135-0019-50 · Chartwell RX, LLC · $0.19403 per EA · eff. 2026-09-23 filed
  • 68382-0792-01 · Zydus Pharmaceuticals (USA) Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 68382-0792-05 · Zydus Pharmaceuticals (USA) Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 69367-0138-01 · Westminster Pharmaceuticals, LLC · $0.19403 per EA · eff. 2026-09-23 filed
  • 69367-0138-05 · Westminster Pharmaceuticals, LLC · $0.19403 per EA · eff. 2026-09-23 filed
  • 69452-0291-20 · Bionpharma Inc. · $0.19403 per EA · eff. 2026-09-23 filed
  • 69452-0291-30 · Bionpharma Inc. · $0.19403 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name acyclovir with ACYCLOVIR 800 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ACYCLOVIR 5% CREAM
generic · cream
$8.99159 per GM filed
eff. 2026-09-23
We don’t know yet
ACYCLOVIR 5% OINTMENT
generic · ointment
$0.34585 to $0.52214 per GM filed
eff. 2026-09-23
We don’t know yet
ACYCLOVIR 200 MG CAPSULE
generic · capsule
$0.09773 per EA filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
ACYCLOVIR 200 MG/5 ML SUSP
generic · suspension
$0.07643 per ML filed
eff. 2026-09-23
We don’t know yet
ACYCLOVIR 400 MG TABLET
generic · tablet
$0.09623 per EA filed
eff. 2026-09-23
We don’t know yet
ACYCLOVIR 800 MG TABLET this page
generic · tablet
$0.19403 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 20 NDCs’ NADAC prices is $0.19403 per EA filed.

Of the 6 other products in FDA’s Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 4 have a higher middle NADAC price and 2 a lower one. The one in the middle is VALACYCLOVIR HCL 500 MG TABLET, at $0.22889 per EA filed (eff. 2026-09-23).

Of the 6 other products in FDA’s Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 4 have a higher middle NADAC price and 2 a lower one. The one in the middle is VALACYCLOVIR HCL 500 MG TABLET, at $0.22889 per EA filed (eff. 2026-09-23).

Of the 9 other products in FDA’s Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 7 have a higher middle NADAC price and 2 a lower one. The one in the middle is VALACYCLOVIR HCL 1 GRAM TABLET, at $0.41001 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.